HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 481 | 609 | 79.0% | |
| HF 4 | 2012 | 591 | 716 | 82.5% | |
| HF 4 | 2013 | 755 | 843 | 89.6% | |
| HF004 | 2014 | 603 | 630 | 95.7% | |
| HF004 | 2015 | 638 | 659 | 96.8% | |
| HF004 | 2016 | 688 | 713 | 96.5% | |
| HF004 | 2017 | 765 | 788 | 97.1% | |
| HF004 | 2018 | 861 | 897 | 96.0% | |
| HF004 | 2019 | 906 | 941 | 96.3% | |
| HF004 | 2020 | 1026 | 1078 | 95.2% | |
| HF006 | 2021 | 1220 | 1350 | 90.4% | |
| HF006 | 2022 | 1628 | 1728 | 94.2% | |
| HF006 | 2023 | 1810 | 1892 | 95.7% |
